HSSB1 (NABP2/OBFC2B) modulates the DNA damage and androgen‐induced transcriptional response in prostate cancer. Issue 7 (22nd February 2023)

• Record Type: Journal Article
• Authors: Adams, Mark N.; Croft, Laura V.; Urquhart, Aaron; Saleem, Mohamed Ashick Mohamed; Rockstroh, Anja; Duijf, Pascal H. G.; Thomas, Patrick B.; Ferguson, Genevieve P.; Najib, Idris Mohd; Shah, Esha T.; Bolderson, Emma; Nagaraj, Shivashankar; Williams, Elizabeth D.; Nelson, Colleen C.; O'Byrne, Kenneth J.; Richard, Derek J.
• Is Part Of: Prostate. Volume 83:Issue 7(2023)
• Page Start: 628
• Page End: 640
• Publication Date: 2023-02-22
• Subjects: androgen receptor -- DNA damage -- hSSB1/NABP2 -- prostate cancer -- radiation; Prostate -- Diseases -- Periodicals; 616
• DOI: 10.1002/pros.24496
• Languages: English
• ISSNs: 0270-4137

Abstract

Abstract: Background: Activation and regulation of androgen receptor (AR) signaling and the DNA damage response impact the prostate cancer (PCa) treatment modalities of androgen deprivation therapy (ADT) and radiotherapy. Here, we have evaluated a role for human single‐strand binding protein 1 (hSSB1/NABP2) in modulation of the cellular response to androgens and ionizing radiation (IR). hSSB1 has defined roles in transcription and maintenance of genome stability, yet little is known about this protein in PCa. Methods: We correlated hSSB1 with measures of genomic instability across available PCa cases from The Cancer Genome Atlas (TCGA). Microarray and subsequent pathway and transcription factor enrichment analysis were performed on LNCaP and DU145 prostate cancer cells. Results: Our data demonstrate that hSSB1 expression in PCa correlates with measures of genomic instability including multigene signatures and genomic scars that are reflective of defects in the repair of DNA double‐strand breaks via homologous recombination. In response to IR‐induced DNA damage, we demonstrate that hSSB1 regulates cellular pathways that control cell cycle progression and the associated checkpoints. In keeping with a role for hSSB1 in transcription, our analysis revealed that hSSB1 negatively modulates p53 and RNA polymerase II transcription in PCa. Of relevance to PCa pathology, our findings highlight a transcriptional role for hSSB1 in regulating the androgen response. We identified that AR function is predicted to be impacted by hSSB1 depletion, whereby this protein is required to modulate AR gene activity in PCa. Conclusions: Our findings point to a key role for hSSB1 in mediating the cellular response to androgen and DNA damage via modulation of transcription. Exploiting hSSB1 in PCa might yield benefits as a strategy to ensure a durable response to ADT and/or radiotherapy and improved patient outcomes.